Metoprolol Tartrate Generics [uk] (Metoprolol Tartrate)

Metoprolol Tartrate is a selective β1‑adrenergic blocker used in cardiovascular disease management.

• Hypertension: lowers systemic blood pressure by reducing cardiac output.
• Angina pectoris: decreases myocardial oxygen demand, relieving chest pain.
• Post‑myocardial infarction: reduces risk of recurrent infarction and improves survival.
• Heart failure: improves left‑ventricular function and reduces hospitalisation.
• Cardiac arrhythmias: controls heart rate in atrial fibrillation and other supraventricular tachyarrhythmias.

• Metoprolol Tartrate selectively antagonises β1‑adrenergic receptors in cardiac tissue, inhibiting catecholamine‑induced stimulation. This reduces heart rate, myocardial contractility, and cardiac output, leading to lower arterial pressure and decreased myocardial oxygen consumption, while preserving β2‑mediated bronchial and vascular effects.

Metoprolol Tartrate may cause a range of adverse reactions.

Common Side Effects

• Fatigue or tiredness.
• Dizziness or light‑headedness, especially on standing.
• Bradycardia (slow heart rate).
• Gastrointestinal discomfort such as nausea or abdominal pain.

Serious or Rare Side Effects

• Severe bradycardia or heart block requiring medical attention.
• Marked hypotension with risk of syncope.
• Bronchospasm in patients with reactive airway disease.

Before initiating therapy, clinicians should consider several safety factors.

• Blood pressure monitoring: ensure adequate control and avoid excessive hypotension.
• Cardiac function assessment: evaluate for heart block or severe bradycardia.
• Respiratory caution: use carefully in patients with asthma or chronic obstructive pulmonary disease.
• Dose adjustment: consider renal or hepatic impairment when titrating.
• Discontinuation: avoid abrupt withdrawal to prevent rebound hypertension or tachycardia.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Metoprolol Tartrate can interact with several drug classes, influencing efficacy or safety.

Major Interactions (Avoid)

• Verapamil or diltiazem: additive negative‑chronotropic effects may cause severe bradycardia.
• Clonidine: abrupt discontinuation after concurrent use can precipitate hypertensive crisis.
• Insulin or oral hypoglycemics: β‑blockade may mask hypoglycaemia symptoms.

Moderate Interactions (Monitor Closely)

• Diuretics: may enhance antihypertensive effect, requiring blood pressure monitoring.
• ACE inhibitors or ARBs: combined therapy can increase risk of hypotension.
• NSAIDs: may reduce the antihypertensive efficacy of metoprolol.